Centers for Disease Control and Prevention - ERA

Description

The purpose of this project is to: 1) continue a birth defects surveillance system implemented under award #1U01GH000487 in four main hospitals in Kampala, Uganda focusing on major external structural birth defects; and 2) conduct a nested case-control study concurrently with the surveillance to determine if maternal use of cotrimoxazole or ARTs during very early pregnancy is associated with a higher risk of birth defects in newborns. Results from this study will provide background rates of birth defects in Kampala and provide baseline estimates of maternal medication use to treat HIV/AIDS in pregnancy and the prevalence of major external birth defects.

Who can apply

• Public and State controlled institutions of higher education
• Private institutions of higher education

Contact

CDC Technical Information Management Section (TIMS) <br/>Telephone 770-488-2700 <br/>ogstims@cdc.gov <br/> <br/>Hours: Monday - Friday, 7am – 4:30pm U.S. Eastern Time <br/> <br/>
ogstims@cdc.gov